|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/13 | (2015.01) |
| A61K 38/37 | (2006.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61P 7/02 | (2006.01) | ||
| A61P 7/04 | (2006.01) |
| (11) | Number of the document | 2310043 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09777111.7 |
| Date of filing the European patent application | 2009-07-10 | |
| (97) | Date of publication of the European application | 2011-04-20 |
| (45) | Date of publication and mention of the grant of the patent | 2012-09-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2009/005027 |
| Date | 2009-07-10 |
| (87) | Number | WO 2010/003687 |
| Date | 2010-01-14 |
| (30) | Number | Date | Country code |
| 102008032361 | 2008-07-10 | DE |
| (72) |
DICKNEITE, Gerhard, DE
PRAGST, Ingo, DE
LESSA, Henrique, DE
HAAS, Thorsten, AT
ZEITLER, Stefan, DE
|
| (73) |
CSL Behring GmbH,
Emil-von-Behring-Strasse 76, 35041 Marburg,
DE
|
| (54) | VON WILLEBRAND FACTOR OR FACTOR VIII AND VON WILLEBRAND FACTOR FOR THE TREATMENT OF COAGULOPATHY INDUCED BY INHIBITORS OF THROMBOCYTES |
| VON WILLEBRAND FACTOR OR FACTOR VIII AND VON WILLEBRAND FACTOR FOR THE TREATMENT OF COAGULOPATHY INDUCED BY INHIBITORS OF THROMBOCYTES |